✦ LIBER ✦

908 REAL-WORLD EFFICACY OF BOCEPREVIR IN COMBINATION WITH PEGINTERFERON alfa-2a AND RIBAVIRIN IN TREATMENT-EXPERIENCED PATIENTS: INTERIM ANALYSIS FROM THE GERMAN NON-INTERVENTIONAL PAN STUDY

✍ Scribed by Spengler, U.; Schober, A.; John, C.; Bruch, H.R.; Heyne, R.; Antoni, C.; Herrmann, A.; Schott, E.; Steffens, H.; Hoerster, H.-G.; Hueppe, D.; Alshuth, U.; Mauss, S.; Buggisch, P.

Book ID: 122630945
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 58 KB
Volume: 58
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(13)60910-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

875 REAL-WORLD EFFICACY AND SAFETY OF BO

875 REAL-WORLD EFFICACY AND SAFETY OF BOCEPREVIR IN COMBINATION WITH PEGINTERFERON alfa-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: INTERIM ANALYSIS FROM THE GERMAN NON-INTERVENTIONAL PAN STUDY

✍ Moog, G.; Schober, A.; Antoni, C.; Bruch, H.R.; Herrmann, A.; John, C.; Steffens 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 74 KB

871 REAL-WORLD EFFICACY AND SAFETY OF TE

871 REAL-WORLD EFFICACY AND SAFETY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON alfa-2a AND RIBAVIRIN: INTERIM ANALYSIS FROM THE GERMAN NON-INTERVENTIONAL PAN STUDY

✍ Mauss, S.; Boeker, K.H.W.; Eisenbach, C.; Moeller, B.; Moog, G.; Lutz, T.; Nauma 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Sa1050 Efficacy of Boceprevir Based Trip

Sa1050 Efficacy of Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1: The PAN Study

✍ Moog, Gero; Mauss, Stefan; Hueppe, Dietrich; Spengler, Ulrich; Schott, Eckart; E 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Sa1041 Triple Therapy Under Real Life Co

Sa1041 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) and Boceprevir (BOC) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1. the PAN Study

✍ Moog, Gero; Mauss, Stefan; Hueppe, Dietrich; Spengler, Ulrich; Schott, Eckart; E 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 285 KB

805 WEEK 4 AND 12 EFFICACY OF TELAPREVIR

805 WEEK 4 AND 12 EFFICACY OF TELAPREVIR (TVR) IN COMBINATION WITH PEGINTERFERON alfa 2a/RIBAVIRIN (P/R) IN TREATMENT EXPERIENCED PATIENTS WITH GT-1 UNDER REAL LIFE CONDITIONS

✍ Christensen, S.; Mauss, S.; Eisenbach, C.; Jung, M.-C.; Roessle, M.; Emke, F.; P 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 59 KB

P1150 BASELINE CHARACTERISTICS AND TREAT

P1150 BASELINE CHARACTERISTICS AND TREATMENT EFFICACY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA-2a AND RIBAVIRIN IN 253 HCV GENOTYPE 1 NONRESPONDER PATIENTS IN A REAL-WORLD SETTING

✍ Hofmann, W.P.; Mauss, S.; Baumgarten, A.; Boeker, K.H.W.; Link, R.; Naumann, U.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB